- Corrigendum to “A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD” [Respir. Med. 120 November 2016 16–24] (S0954611116302359) (10.1016/j.rmed.2016.09.012)). Respiratory Medicine. 2017 Article GET IT
Respiratory symptoms items from the COPD assessment test identify ever-smokers with preserved lung function at higher risk for poor respiratory outcomes an analysis of the subpopulations and intermediate outcome measures in COPD Study cohort.
Annals of the American Thoracic Society.
Times cited: 4